LipoNova AG: Local Supervisory Agency Approves Production license of LipoNova’s Early-Stage Kidney Cancer Vaccine Reniale®   ***   LipoNova AG reaches key milestones in the Reniale development process during 2007. Costs below budget.   ***   LipoNova signs memorandum of understanding for the marketing of Reniale®   ***   
Our Team

The LipoNova Team

LipoNova AG has approximately 30 employees, including experienced pharmaceutical scientists and business experts, based at our headquarters in Hannover, Germany.

Our management team brings together a broad range of experts: they combine big pharma experience with biotech entrepreneurialism, and valuable commercial skills gained in other sectors. The management team works closely with its Clinical and International Advisory Boards, and with an extensive network of specialists and development groups.